Alpha Omega Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.53M Sell
26,593
-200
-0.7% -$11.5K 0.23% 104
2026
Q1
$1.62M Sell
26,793
-98
-0.4% -$5.71K 0.26% 96
2025
Q4
$1.45M Sell
26,891
-674
-2% -$32.4K 0.24% 102
2025
Q3
$1.24M Sell
27,565
-2,375
-8% -$111K 0.21% 108
2025
Q2
$1.39M Sell
29,940
-190
-0.6% -$9.33K 0.25% 101
2025
Q1
$1.84M Buy
30,130
+439
+1% +$25.6K 0.35% 82
2024
Q4
$1.68M Buy
29,691
+257
+0.9% +$14.4K 0.32% 88
2024
Q3
$1.52M Sell
29,434
-1,664
-5% -$78.1K 0.28% 95
2024
Q2
$1.29M Sell
31,098
-5,873
-16% -$263K 0.25% 98
2024
Q1
$2M Sell
36,971
-674
-2% -$34.3K 0.37% 83
2023
Q4
$1.93M Sell
37,645
-300
-0.8% -$15.7K 0.32% 84
2023
Q3
$2.2M Sell
37,945
-2,619
-6% -$160K 0.38% 75
2023
Q2
$2.59M Sell
40,564
-471
-1% -$31.6K 0.44% 63
2023
Q1
$2.84M Sell
41,035
-476
-1% -$33.6K 0.49% 57
2022
Q4
$2.99M Sell
41,511
-600
-1% -$45.2K 0.53% 56
2022
Q3
$2.99M Sell
42,111
-717
-2% -$52K 0.57% 56
2022
Q2
$3.3M Sell
42,828
-939
-2% -$71.5K 0.59% 52
2022
Q1
$3.2M Sell
43,767
-443
-1% -$29.7K 0.51% 58
2021
Q4
$2.86M Sell
44,210
-447
-1% -$26.2K 0.44% 69
2021
Q3
$2.64M Buy
44,657
+645
+1% +$42.5K 0.43% 71
2021
Q2
$2.94M Sell
44,012
-499
-1% -$32.5K 0.48% 65
2021
Q1
$2.81M Sell
44,511
-315
-0.7% -$19.6K 0.49% 62
2020
Q4
$2.78M Sell
44,826
-912
-2% -$56.1K 0.47% 59
2020
Q3
$2.76M Sell
45,738
-50
-0.1% -$3.01K 0.39% 52
2020
Q2
$2.69M Sell
45,788
-355
-0.8% -$21.2K 0.41% 51
2020
Q1
$2.57M Sell
46,143
-103
-0.2% -$6.3K 0.47% 44
2019
Q4
$2.97M Buy
46,246
+1,217
+3% +$69.7K 0.48% 53
2019
Q3
$2.61M Buy
45,029
+31,680
+237% +$1.49M 0.42% 58
2019
Q2
$605K Sell
13,349
-100
-0.7% -$4.66K 0.26% 77
2019
Q1
$642K Buy
13,449
+330
+3% +$16.4K 0.29% 72
2018
Q4
$682K Buy
13,119
+94
+0.7% +$5.05K 0.34% 64
2018
Q3
$809K Hold
13,025
0.36% 60
2018
Q2
$721K Sell
13,025
-807
-6% -$43.6K 0.35% 63
2018
Q1
$875K Buy
13,832
+110
+0.8% +$7.08K 0.44% 57
2017
Q4
$841K Sell
13,722
-250
-2% -$15.6K 0.41% 60
2017
Q3
$891K Sell
13,972
-608
-4% -$35.5K 0.44% 57
2017
Q2
$812K Hold
14,580
0.42% 61
2017
Q1
$793K Buy
14,580
+600
+4% +$32.9K 0.42% 59
2016
Q4
$817K Buy
13,980
+13,972
+174,650% +$764K 0.43% 59
2016
Q3
$0 Hold
8
﹤0.01% 216
2016
Q2
$1K Hold
8
﹤0.01% 211
2016
Q1
$1K Hold
8
﹤0.01% 212
2015
Q4
$1K Buy
+8
New +$529 ﹤0.01% 204

Other funds holding BMY

Alpha Omega Wealth Management's BMY Position: Q2 2026 in Review

Alpha Omega Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 0.75% in Q2 2026, selling an estimated $11.5K and leaving 26,593 shares worth $1.53M. The position accounts for 0.23% of the portfolio, ranked #104.

Alpha Omega Wealth Management first reported a position in BMY in Q4 2015 and has held it in 43 quarters since. The position peaked at $3.3M in Q2 2022. 879 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Alpha Omega Wealth Management held 26,593 shares of Bristol-Myers Squibb worth $1.53M as of Q2 2026.
  • Alpha Omega Wealth Management sold 200 Bristol-Myers Squibb shares in Q2 2026, an estimated $11.5K.
  • Bristol-Myers Squibb made up 0.23% of Alpha Omega Wealth Management's portfolio in Q2 2026, its #104 holding.
  • Alpha Omega Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2015 and has held it in 43 quarters since.
  • Alpha Omega Wealth Management's Bristol-Myers Squibb position peaked at $3.3M in Q2 2022.
  • 879 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Alpha Omega Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.